发明授权
- 专利标题： Hepatitis C virus inhibitors
- 专利标题（中）： 丙型肝炎病毒抑制剂
-
申请号： US13670691申请日： 2012-11-07
-
公开(公告)号： US08735398B2公开(公告)日： 2014-05-27
- 发明人: Omar D. Lopez , Denis R. St. Laurent , Jason Goodrich , Jeffrey Lee Romine , Michael Serrano-Wu , Fukang Yang , Ramesh Kakarla , Xuejie Yang , Yuping Qiu , Lawrence B. Snyder
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： US NJ Princeton
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： US NJ Princeton
- 代理商 Pamela A. Mingo
- 主分类号： C07D249/08
- IPC分类号： C07D249/08 ; C07D231/12 ; C07D413/14 ; C07D233/58 ; A61K31/4196 ; A61K31/4245 ; A61K31/415
摘要：
The present disclosure is generally directed to antiviral compounds, and more specifically directed to compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such compounds, and methods for inhibiting the function of the NS5A protein.
公开/授权文献
- US20130085147A1 Hepatitis C Virus Inhibitors 公开/授权日：2013-04-04
信息查询
